SIRT3 and cancer: Paku et al. demonstrated that sirtuin 3 (SIRT3) increased colorectal cancer cell chemoresistance through SOD2 and PGC-1α up-regulation, and SIRT3 inhibition sensitized cancer cells to the chemotherapy [129].